@misc{indiciae05a13bcc434e,
  title = {Pharmacological inhibition of CXCR4 increases the anti-tumor activity of conventional and targeted therapies in B-cell lymphoma models},
  author = {Barnabei, L. and Arribas, A. J. and Cascione, L. and Guidetti, F. and Spriano, F. and Tarantelli, C. and Di Cristofano, S. and Raniolo, S. and Rinaldi, A. and Stathis, A. and Rossi, D. and Zucca, E. and Limongelli, V. and Zimmermann, J. and Bertoni, F.},
  year = {2025},
  doi = {10.1101/2025.07.10.664047},
  url = {https://www.biorxiv.org/content/10.1101/2025.07.10.664047v1},
  note = {Source identifier: 10.1101/2025.07.10.664047}
}